Markets › United States › NYSE › MANE

Veradermics Inc

NYSE:MANEHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$127.11+3.95%At closeAt close · Wed 21 Oct · ≈ AED 466.81 · Market cap $5.31B · Next earnings Tue 10 Nov

USD millions	FY2023	FY2024	FY2025	YoY
Cash & cash equivalents	16.3	53.1	21.8	−59.0%
Cash & short-term investments	16.3	53.1	141.9	+167.2%
Receivables	0.0	1.4	1.3	−8.7%
Inventory	0.0	0.0	0.0	—
Total current assets	17.6	55.5	152.5	+174.6%
Property, plant & equipment	0.0	0.0	0.1	—
Goodwill & intangibles	0.0	0.0	0.0	—
Long-term investments	0.9	3.8	0.0	−100.0%
Total assets	18.5	59.4	152.6	+157.0%
Payables	1.9	2.2	2.1	−5.4%
Short-term debt	0.0	0.0	0.0	—
Total current liabilities	3.1	4.7	9.2	+94.0%
Long-term debt	0.8	0.0	0.0	—
Total debt	0.8	0.0	0.0	—
Net debt	(15.5)	(53.1)	(21.8)	+59.0%
Deferred revenue	0.0	0.0	0.0	—
Total liabilities	3.8	4.7	273.6	+5699.8%
Total equity	14.6	54.7	(121.0)	−321.4%
Retained earnings	(22.7)	(49.2)	(123.4)	−150.7%